drugset / Trial / NCT04430595
Multi-4SCAR-T Therapy Targeting Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the feasibility, safety and efficacy of multiple 4th generation CAR-T cells targeting Her2, GD2, and CD44v6 surface antigen in breast cancer. Another goal of the study is to learn more about the activities of the multi-CAR T cells and their persistency in the patients.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2029-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4SCAR-CD44v6 | Cell therapy | — | Other |
| Subject | 4SCAR-GD2 | Cell therapy | — | Other |
| Subject | 4SCAR-Her2 | Cell therapy | — | Other |